Ascending Aortic Dilation in BiAV After TAVR

NCT03051334 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2017-02-13

No results posted yet for this study

Summary

This study sought to evaluate changes in ascending aorta size after transcatheter aortic valve replacement (TAVR) in patients with bicuspid aortic valve (BiAV) compared with patients with tricuspid aortic valve (TAV).

Conditions

  • Aortic Valve Stenosis

Interventions

OTHER

diagnosed as bicuspid aortic valve

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-01
Primary Completion
2017-12-30
Completion
2017-12-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03051334 on ClinicalTrials.gov